About 4.4% of the global population currently lives with an anxiety disorder, according to the World Health Organization. That translates to roughly 350 million people worldwide. The number climbed sharply during the COVID-19 pandemic, and rates remain elevated in many countries.
How the Pandemic Changed the Numbers
Before 2020, global anxiety prevalence had been holding relatively steady at around 3.6% to 4% for years. Then, in the first year of the COVID-19 pandemic, the global prevalence of anxiety and depression jumped by 25%. Lockdowns, social isolation, economic uncertainty, fear of illness, and grief all contributed to the surge. That spike didn’t fully reverse once restrictions lifted, which is why the current estimate sits at 4.4%.
Women Are Diagnosed Nearly Twice as Often
Anxiety disorders affect women at significantly higher rates than men. In large national surveys, between 30.5% and 33% of women received an anxiety diagnosis at some point in their lives, compared to 19% to 22% of men. Women are also more likely to have more than one anxiety disorder at the same time: 44.8% of women with anxiety had a second overlapping anxiety condition, versus 34.2% of men.
The gap shows up across nearly every type of anxiety disorder and across cultures. Hormonal fluctuations, differences in stress response, and the fact that women are more likely to experience certain risk factors (like interpersonal violence) all play a role. Some researchers also point out that men may underreport symptoms or avoid seeking help, which could make the gap appear wider than it truly is in biological terms.
Anxiety in Children and Teenagers
Anxiety isn’t only an adult condition. An estimated 4.1% of children ages 10 to 14 and 5.3% of teenagers ages 15 to 19 experience an anxiety disorder. The slightly higher rate in older adolescents reflects the added pressures of academic performance, social identity, and increasing independence. For many adults who live with anxiety, symptoms first appeared during adolescence, making early recognition especially important.
Types of Anxiety Disorders and How Common They Are
The 4.4% global figure bundles several distinct conditions together. Each one has a different pattern, and some are far more common than others.
Generalized anxiety disorder (GAD) involves persistent, hard-to-control worry about everyday things like health, finances, family, and work. To meet diagnostic criteria, those feelings need to last for at least several months, more days than not, and come with physical symptoms like muscle tension, restlessness, trouble sleeping, or stomach problems like nausea and palpitations. The worry has to be severe enough to interfere with daily life.
Social anxiety disorder is more common than many people realize. In the United States, about 7.1% of adults experience it in any given year, and roughly 12.1% will deal with it at some point in their lives. Women are affected more often (8.0%) than men (6.1%). Among those with social anxiety, nearly 30% report serious impairment in their ability to function at work, school, or in relationships. About 9.1% of adolescents also experience social anxiety, with higher rates in girls (11.2%) than boys (7.0%).
Panic disorder and specific phobias (intense fear of particular things like heights, flying, or needles) round out the most common subtypes. Phobias are actually among the most prevalent anxiety disorders globally, though they often go undiagnosed because people simply avoid the trigger rather than seeking treatment.
What Counts as a Diagnosed Case
The 4.4% figure refers to people who meet formal diagnostic criteria, not everyone who feels anxious. To be counted, a person’s symptoms need to persist for months, cause real disruption to their daily functioning, and not be explained by another medical condition or substance use. The core symptoms include excessive worry or a sense of free-floating dread, along with physical signs: muscle tension, a racing heart, sweating, trembling, difficulty concentrating, irritability, and trouble sleeping.
This matters because everyday anxiety, the kind you feel before a job interview or during a stressful week, is universal and doesn’t qualify as a disorder. The global prevalence numbers capture only people whose anxiety is persistent, impairing, and clinically significant. That means the true burden of problematic anxiety, including people with symptoms just below the diagnostic threshold, is almost certainly higher than 4.4%.
Most People With Anxiety Go Untreated
One of the starkest realities is the treatment gap. In low- and middle-income countries, the vast majority of people with anxiety disorders never receive any form of treatment, whether therapy, medication, or structured support. Even in wealthier nations with well-funded healthcare systems, many people wait years before seeking help or never do at all. Barriers include cost, stigma, limited access to mental health professionals, and the widespread belief that anxiety is just a personality trait rather than a treatable condition.
Effective treatments exist. Cognitive behavioral therapy has decades of evidence behind it, and several classes of medication can reduce symptoms substantially. The challenge is connecting the hundreds of millions of people who need help with the resources that already work.